洁特生物：关于使用部分闲置募集资金暂时补充流动资金的公告

Core Viewpoint - Jiet Bio announced the approval of a proposal to temporarily use part of its idle raised funds to supplement working capital, amounting to no more than RMB 200 million [1] Group 1: Company Actions - The company held its 27th meeting of the fourth board of directors on January 19, 2026, where the proposal was reviewed and approved [1] - The approved funds will be used for production and operational activities related to the company's main business [1] - The usage period for the funds is set to be no more than 12 months from the date of board approval, with the possibility of rolling use within this limit [1]